About Intas B2B

Since March 2005, Intas B2B has become an active pharmaceutical licensor, proud to supply more than 140 different finished products to 90+ partners in EMEA, APAC, CANADA and LATAM.

GMP sites approved by key Health Authorities

Cost efficient & large manufacturing capabilities

Long experience in license & supply to regulated markets

Wide portfolio and innovative pipeline

Fully fledged team for customers’ satisfaction

For more information about IntasB2B or enquiries about our dossiers, please contact us

About Intas Group

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies, with presence in more than 85 countries across the world. 

Currently ranked 8th (as per IQVIA TSA MAT January 2021) in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. 

Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations. The company is composed by a full fledged global support team of 18,000+ employees.

$ .1
Billion Turnover
Annual Growth
cGMP manufacturing sites approved for US and EU